DEGUM III guideline for level II ultrasound examinations at 11-14 weeks of gestation;DEGUM-stufe-III-empfehlung zur "weiterführenden" sonographischen untersuchung (=DEGUM-Stufe II) im zeitraum 11-14 schwangerschaftswochen

Ultraschall in der Medizin

Volumn 25, Issue 3, 2004, Pages 218-220

  Merz, E ^a   Meinel, K ^a   Bald, R ^a   Bernaschek, G ^a   Deutinger, J ^a   Eichhorn, K ^a   Feige, A ^a   Grab, D ^a   Hackeloer B J ^a   Hansmann, M ^a   Kainer, F ^a   Schillinger, W ^a   Schneider, K T M ^a   Staudach, A ^a   Steiner, H ^a   Tercanli, S ^a   Terinde, R ^a   Wisser, J ^a  

^a KRANKENHAUS NORDWEST   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; PRACTICE GUIDELINE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; REVIEW; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; ULTRASOUND;

EID: 2942595925     PISSN: 01724614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Nicolaides KH, Azar G, Byrne D et al. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. Br Med J 1992; 304: 867-889
2. Snijders RJM, Noble P, Sebire N et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet 1998; 351: 343-346
3. Wald NJ, George L, Smith D et al. On behalf of the International Prenatal Screening Research Group. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. Br J Obstet Gynaecol 1996; 104: 407-412
4. Cuckle HS, van Lith JM. Appropriate biochemical parameters in firsttrimester screening for Down syndrome. Prenat Diagn 1999; 19: 505-512
5. Spencer K, Souter V, Tul N et al. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β9-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999; 13: 231-237
6. Nicolaides KH, Cicero S, Liao AW. One-stop clinic assessment of risk of chromosomal defects at 12 weeks of gestation. Prenat Neonat Med 2000; 5: 145-154
7. Gaziorek-Wiens A, Tercanli S et al. on behalf of the German Speaking Down Syndrome Screening Group. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland. Ultrasound Obstet Gynecol 2001; 18: 645-648
8. Rempen A, Chaoui R, Kozlowski P et al. Standards zur Ultraschalluntersuchung in der Frühschwangerschaft. Empfehlungen der DEGUM-Stufe III (Deutsche Gesellschaft für Ultraschall in der Medizin) Sektion Gynäkologie und Geburtshilfe, und der ARGUS (Arbeitsgemeinschaft für Ultraschalldiagnostik der DGGG). Ultraschall in Med 2001; 22: M1-M5
9. Merz E, Eichhorn KH, Hansmann et al. Qualitätsanforderungen an die weiterführende differentialdiagnostische Ultraschalluntersuchung in der pränatalen Diagnostik (=DEGUM II) im Zeitraum 18 bis 22 Schwangerschaftswochen. Ultraschall in Med 2002; 23: 11-12